Creso Pharma Ltd
ASX:CPH
Cash Flow Statement
Cash Flow Statement
Creso Pharma Ltd
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
(0)
|
|
| Cash from Operating Activities |
(10)
N/A
|
(22)
-133%
|
(17)
+23%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(1)
|
(2)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-65%
|
(2)
-67%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
11
|
25
|
9
|
|
| Net Issuance of Debt |
5
|
(0)
|
5
|
|
| Other |
(2)
|
0
|
(0)
|
|
| Cash from Financing Activities |
14
N/A
|
25
+82%
|
14
-45%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
3
N/A
|
1
-65%
|
(6)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(10)
N/A
|
(23)
-127%
|
(18)
+23%
|
|